CAMBRIDGE, Mass., December 15, 2020-- nference, which synthesizes the world's biomedical knowledge, announced completion of a $60 million Series C funding round led by Matrix Capital Management, along with Matrix Partners, Mayo Clinic Ventures and NTTVC. "nference – a science-first software company – continues to push the boundaries of augmented intelligence to accelerate the work of our expert scientists and technologists in making biomedical knowledge computable via our nferXTM software platform," said Murali Aravamudan, co-founder and chief executive officer. "This funding enables expansion of our portfolio, which is catalyzing development of meaningful diagnostics and therapeutics.